What happens when a strong health supplement offer meets platform compliance friction on Google, Meta, and Microsoft Ads all at once? In this case, it meant a brand with real demand kept hitting an artificial ceiling.
At Positive Sparks, we worked with a health supplement brand that wanted to scale beyond a single-channel setup and build a proper multi-platform acquisition engine. The commercial case was there. Average order value was healthy, repeat purchase behaviour was solid, and early conversion rates showed room to grow. The problem was compliance. In month one, 40% of product ads were rejected because of non-compliant claims, which meant delayed launches, unstable learning phases, and wasted creative production time.
1. The challenge
Why was scaling so difficult if the product economics already worked? Because performance marketing for health brands is never just about bids, audiences, and landing pages. It is also about claim control.
This brand had creative angles written for conversion, but not always for platform policy. Some headlines leaned too close to implied outcomes. Some body copy used language that sounded acceptable internally but triggered policy filters externally. You know how this goes: one phrase gets flagged, then an entire batch of ads stalls.
The immediate issue was simple. The brand wanted to scale across Google, Meta, and Microsoft Ads, but the approval process was inconsistent and painful. With 4 in 10 ads disapproved in the first month, media buying became reactive instead of strategic.
Actionable takeaway: if your disapproval rate is above 10%, do not treat it as a creative annoyance. Treat it as a growth constraint with a measurable revenue cost.
2. The compliance framework we built
So how did we fix it without killing performance? We built a framework the legal team and the media team could both use.
First, we created a master list of 50 approved claims and had them signed off by the brand’s legal team before campaign expansion. Then we grouped those claims into three practical categories:
- Structure-function claims like support for normal body processes
- General wellness claims tied to lifestyle and wellbeing
- Nutrient content claims focused on ingredient composition and measurable product facts
Every ad variation, from headline to primary text to image overlay, was mapped against that approved list before launch. If a claim was not on the list, it did not go live. That rule alone removed a huge amount of last-minute guesswork.
We also built a pre-launch review step inside the workflow so copywriters, designers, and buyers were all working from the same source of truth.
Actionable takeaway: create one approved-claims document, assign an owner, and make launch approval binary: on the list or not on the list.
3. The platform differences
Did all three platforms enforce policy the same way? Not even close.
Meta rejected 3x more ads for “exaggerated claims” than Google, especially when creative implied dramatic outcomes or transformation-based language. Microsoft Ads was the strictest on “cure” language, even when that wording appeared in secondary copy concepts that had passed internal review. Google was still strict, but comparatively more predictable once the copy framework was tightened.
That meant we had to stop thinking about compliance as one universal standard and start treating it as platform-specific execution.
For Meta, we softened claims, reduced implication-heavy visuals, and focused on support-oriented phrasing. For Google, we aligned search ad copy tightly with approved terminology and landing page language. For Microsoft, we removed any copy that came close to disease-treatment framing and kept the tone especially factual.
Actionable takeaway: build one compliance foundation, then create platform-specific creative rules on top of it. The same product benefit should be expressed three different ways if needed.
4. The results
What changed once the framework was live? Quite a lot, actually.
After implementation, the brand’s ad disapproval rate dropped from 40% to 4%. That gave us far more stable campaign deployment, faster testing cycles, and fewer interruptions to spend scaling. Over the next 5 months, blended ROAS reached 4.2x, and monthly revenue grew from $45k to $200k.
That growth did not come from finding some secret hack. It came from making compliance operational. Once approvals became predictable, we could spend more time improving creative, landing page alignment, and budget allocation instead of rewriting flagged ads every week.
5. The takeaway
Is compliance a bottleneck? In our experience, no. It is a moat.
Most health brands still treat compliance as something to check after creative is finished. Bear in mind, that approach usually creates slower launches, more rejected ads, and less scale. The brands that get this right face less friction, keep more campaigns live, and often compete in auctions with fewer serious advertisers.
At Positive Sparks, we’ve seen the same pattern repeatedly: when compliance becomes part of the growth system, scale becomes much easier to sustain.
What does your current claims process look like across platforms? Are you still reviewing copy ad by ad, or have you built a framework your legal and media teams can actually scale with?
